YD Bio Ltd SEC filings YDES

YD Bio Ltd has 80 filings in SEC EDGAR's recent list, going back to Feb 14, 2024. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 1, 2026. The company's fiscal year ends on December 31.

YD Bio Ltd SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Sep 1, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 11, 2026 Aug 11, 2026
6-K Current report (foreign issuer) May 1, 2026 Apr 30, 2026
6-K Current report (foreign issuer) Feb 26, 2026 Feb 26, 2026
6-K Current report (foreign issuer) Jan 30, 2026 Jan 30, 2026
6-K Current report (foreign issuer) Jan 21, 2026 Jan 21, 2026
6-K Current report (foreign issuer) Jan 16, 2026 Jan 16, 2026
6-K Current report (foreign issuer) Jan 15, 2026 Jan 15, 2026
6-K Current report (foreign issuer) Jan 6, 2026 Jan 6, 2026
6-K Current report (foreign issuer) Nov 17, 2025 Nov 17, 2025
6-K Current report (foreign issuer) Sep 30, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Sep 26, 2025 Sep 26, 2025
6-K Current report (foreign issuer) Sep 19, 2025 Sep 19, 2025
6-K Current report (foreign issuer) Aug 15, 2025 Aug 15, 2025

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
YDES (Nasdaq), YDESW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Cayman Islands
Headquarters
Taipei City
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2011674
Former names
True Velocity, Inc./DE (until Jun 21, 2024)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.